In brief
Nigeria, facing significant malaria challenges, has officially begun administering the R21/Matrix-M vaccine to children, with a plan for nationwide distribution by next year.
In a significant public health initiative, Nigeria has launched a malaria vaccine rollout, marking the first deployment of such a vaccine in the country, which bears the heaviest burden of malaria globally. With 27% of the world's malaria cases and 31% of deaths reported in 2022, Nigeria's health authorities are hopeful about combating this leading cause of child mortality.The vaccine, known as R21/Matrix-M, has been recognized by the World Health Organization (WHO) and is being administered to infants aged five to 15 months. Health experts stress the importance of integrating the vaccination with existing malaria prevention strategies, such as insecticide-treated nets and indoor spraying.The rollout began in Bayelsa and Kebbi, two states severely impacted by malaria, with plans for expansion throughout the country in the coming year. Happiness Idia-Wilson was among the first to vaccinate her 11-month-old son during an event in Bayelsa, reinforcing her commitment to protecting him through vaccination. "For the safety of the child, for him to be protected," she said, urging fellow mothers to participate in the vaccination program.Bayelsa's health commissioner, Prof Seiyefa Brisibe, emphasized the state's efforts to raise awareness about the vaccine through health campaigns tailored to local languages. With children under five years and pregnant women being the most vulnerable, the WHO representative in Nigeria, Dr. Walter Mulombo, expressed optimism for the new vaccine's potential to significantly reduce malaria-related deaths.The economic impact of malaria is also severe, with the Nigerian government estimating an annual loss of $1.1 billion due to health and productivity costs associated with the disease. The R21/Matrix-M vaccine requires three doses spaced four weeks apart, followed by a booster after a year, and represents a promising advancement in the fight against malaria in Africa.
